Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Fleury S.A.
  6. News
  7. Summary
    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
End-of-day quote. End-of-day quote Bolsa de Valores de Sao Paulo - 09/21
23.74 BRL   +0.68%
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Fleury S.A. completed the acquisition of CIP - Centro de Infusões Pacaembu LTDA.

12/31/2020 EDT

Fleury S.A. (BOVESPA:FLRY3) agreed to acquire CIP - Centro de Infusões Pacaembu LTDA. for BRL 120 million on December 9, 2020. On December 10, 2020, an agreement has been signed. In a related transaction, Fleury Centro de Procedimentos Médicos Avançados SA agreed to acquire 80% stake in Clínica de Olhos Dr. Moacir da Cunha Ltda. on December 9, 2020. CIP - Centro de Infusões Pacaembu LTDA. reported a gross revenue of BRL 108.3 million for the year ended June 30, 2020. The transaction is subject to certain suspensive conditions, including the approval of the Administrative Council for Economic Defense (Cade). As of February 16, 2021, the Administrative Council for Economic Defense (Cade) approved the acquisition. The transaction was unanimously approved by the Board of Directors of Fleury. Fleury S.A. (BOVESPA:FLRY3) completed the acquisition of CIP - Centro de Infusões Pacaembu LTDA. in the fourth quarter of 2020.


© S&P Capital IQ 2020
All news about FLEURY S.A.
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
04/30Fleury to Seek Acquisitions
CI
04/29FLEURY S A : Financial Statements - 1Q21
PU
04/29Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/25Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
02/16Brazil's overwhelmed healthcare system spawns bonanza for dealmakers
RE
More news
Financials
Sales 2021 3 584 M 680 M 680 M
Net income 2021 357 M 67,8 M 67,8 M
Net Debt 2021 1 873 M 355 M 355 M
P/E ratio 2021 21,1x
Yield 2021 3,86%
Capitalization 7 525 M 1 418 M 1 428 M
EV / Sales 2021 2,62x
EV / Sales 2022 2,45x
Nbr of Employees 15 000
Free-Float 54,8%
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 23,74 BRL
Average target price 29,52 BRL
Spread / Average Target 24,3%
EPS Revisions
Managers and Directors
Jeane Mike Tsutsui Chief Executive Officer
José Antônio de Almeida Filippo Director-Finance & Investor Relations
Marcio Pinheiro Mendes Chairman
Edgar Gil Rizzatti Head-Medical, Technical & Process
Andrea Cristina de Lima Rolim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FLEURY S.A.-12.14%1 404
SONIC HEALTHCARE LIMITED29.24%14 499
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-24.16%6 952
NEOGENOMICS, INC.-12.70%5 780
DR. LAL PATHLABS LIMITED71.40%4 422
HEALIUS LIMITED32.17%2 159